ArticleJACC. Asia2026
Prognostic Impact of Residual Thrombus After Aspiration Thrombectomy in ST-Elevation Myocardial Infarction.
Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Thrombus We Leave Behind: Residual Risk After Aspiration Thrombectomy in STEMI.JACC. Asia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognostic significance of residual thrombus volume after aspiration thrombectomy in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear.
objectivesThe authors aimed to investigate whether residual thrombus volume quantified by post-aspiration optical coherence tomography (OCT) is associated with major adverse cardiovascular events (MACE) in patients with STEMI undergoing primary percutaneous coronary intervention (PCI).
methodsThis retrospective single-center study included 233 patients with STEMI who underwent manual aspiration thrombectomy followed by OCT-guided primary PCI within 12 hours of symptom onset. Residual thrombus volume was quantified at 1.0-mm intervals. The optimal cutoff was determined using maximally selected log-rank statistics. The primary endpoint was MACE, defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Associations with MACE were evaluated using Kaplan-Meier and Cox regression analyses.
resultsDuring a median follow-up of 2.5 years (IQR: 1.3-3.5 years), MACE occurred in 46 patients (19.7%). Patients with residual thrombus volume ≥4.14 mm
conclusionsResidual thrombus burden quantified by OCT after aspiration thrombectomy was independently associated with adverse cardiovascular outcomes in patients with STEMI. Quantitative OCT assessment may provide complementary prognostic information for post-PCI risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.